Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is covered...
Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vibration-controlled transient elastography-based prevalence of MASLD in Saudi Arabia: A prospective cohort study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendations.

Expert review of endocrinology & metabolism·2026
Same author

Alcohol-associated liver disease in the MENA region: A 16-country survey of healthcare provider perspectives.

Annals of hepatology·2026
Same author

Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same author

Predictors and outcomes of hepatic decompensation following transarterial locoregional therapy in hepatocellular carcinoma.

Scientific reports·2026
Same author

Changing Cirrhosis Burden in the MENA Region, 1990-2021: From Premature Mortality to Disability (Global Burden of Disease).

Liver international : official journal of the International Association for the Study of the Liver·2026

Related Experiment Video

Updated: Jun 19, 2026

Porcine Normothermic Isolated Liver Perfusion
07:32

Porcine Normothermic Isolated Liver Perfusion

Published on: June 9, 2023

The liver in tuberculous peritonitis.

Faisal M Sanai1

  • 1Department of Hepatology, Armed Forces Hospital, Riyadh, Saudi Arabia. fsanai@rmh.med.sa

Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|October 28, 2009
PubMed
Summary

Tuberculous peritonitis often co-occurs with liver disease, complicating diagnosis and treatment. Understanding this overlap is crucial for effective management of both conditions.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Hepatology

Background:

  • Tuberculous peritonitis is a frequent manifestation of abdominal tuberculosis.
  • Liver disease, particularly cirrhosis, commonly coexists with tuberculous peritonitis.
  • This dual pathology presents significant diagnostic and therapeutic challenges.

Purpose of the Study:

  • To review the prevalence of liver disease in tuberculous peritonitis patients.
  • To highlight the diagnostic difficulties arising from coexistent liver disease.
  • To discuss appropriate treatment strategies for this complex clinical scenario.

Main Methods:

  • Literature review focusing on studies investigating tuberculous peritonitis and liver disease.
  • Analysis of diagnostic challenges and interpretation of tests in the presence of both conditions.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Experiment Videos

Last Updated: Jun 19, 2026

Porcine Normothermic Isolated Liver Perfusion
07:32

Porcine Normothermic Isolated Liver Perfusion

Published on: June 9, 2023

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

  • Synthesis of information on treatment approaches considering potential drug toxicities.
  • Main Results:

    • Coexistence of liver disease and tuberculous peritonitis is common.
    • Diagnostic tests for tuberculous peritonitis can be unreliable in cirrhotic patients.
    • Separate pathogenetic mechanisms for ascites in both diseases complicate interpretation.

    Conclusions:

    • Accurate diagnosis of tuberculous peritonitis in liver disease patients is challenging.
    • Management requires careful consideration of drug hepatotoxicity.
    • Further research is needed to optimize diagnostic and treatment protocols.